Skip to content

What not to do with mirtazapine? A Guide to Precautions and Contraindications

4 min read

In clinical trials, mirtazapine was found to be significantly more effective than some antidepressants in the first weeks of treatment, but it requires careful management to ensure patient safety. Therefore, understanding exactly what not to do with mirtazapine is crucial for anyone prescribed this medication.

Quick Summary

Mirtazapine requires careful adherence to prescribing guidelines, as numerous drug and substance interactions can cause serious side effects like serotonin syndrome or CNS depression. Patients should never stop taking it abruptly, exceed their dose, or combine it with alcohol. Pre-existing medical conditions and age-specific factors also necessitate strict precautions.

Key Points

  • Avoid MAOIs: Do not take mirtazapine with or within 14 days of taking a Monoamine Oxidase Inhibitor due to the risk of serotonin syndrome.

  • Do not drink alcohol: Mixing mirtazapine and alcohol can cause excessive sedation, impaired coordination, and worsen depression.

  • Never stop abruptly: Discontinuation must be gradual and supervised by a doctor to prevent withdrawal symptoms.

  • Don't drive until aware of effects: Wait to see how the medication affects your alertness and motor skills before driving or operating machinery.

  • Exercise caution with comorbidities: Individuals with heart, liver, or kidney problems, glaucoma, or a history of seizures require close monitoring.

  • Watch for suicidal ideation: Patients under 25 and caregivers should be vigilant for any worsening depression, unusual behavior, or suicidal thoughts.

  • Correctly handle tablets: Never split orally disintegrating tablets and only open the blister pack when ready to take a dose.

In This Article

Critical Drug and Substance Interactions to Avoid

Monoamine Oxidase Inhibitors (MAOIs)

Combining mirtazapine with an MAOI is strictly prohibited and can lead to a potentially fatal condition known as serotonin syndrome. Serotonin syndrome is caused by excessive serotonin levels in the brain and can result in severe symptoms such as high fever, rigid muscles, hallucinations, and rapid heart rate. This applies to MAOIs like isocarboxazid, phenelzine, tranylcypromine, and the antibiotic linezolid. A gap of at least 14 days must be observed when switching between mirtazapine and an MAOI.

Alcohol and CNS Depressants

Patients taking mirtazapine should avoid or severely limit alcohol consumption. Both mirtazapine and alcohol can depress the central nervous system (CNS), and their combined effects can lead to excessive drowsiness, dizziness, impaired thinking, and slowed breathing. The same additive sedative effect is seen when combining mirtazapine with other CNS depressants, including:

  • Benzodiazepines (e.g., diazepam, alprazolam)
  • Opioid pain medications (e.g., tramadol, fentanyl)
  • Cannabis (marijuana) and CBD products

Other Serotonergic Drugs

Combining mirtazapine with other medications that increase serotonin levels can also raise the risk of serotonin syndrome, especially at higher doses. These include:

  • Other antidepressants (SSRIs, SNRIs, TCAs)
  • Triptans for migraines (e.g., sumatriptan)
  • Lithium
  • Herbal supplements like St. John's wort and tryptophan

Other Notable Interactions

  • Cytochrome P450 3A4 Modulators: Some drugs can alter how mirtazapine is metabolized, either increasing its concentration (inhibitors like ketoconazole, ritonavir) or decreasing it (inducers like rifampin, phenytoin). Dose adjustments may be necessary under medical supervision.
  • Warfarin: Mirtazapine can potentially increase the effects of the blood thinner warfarin, raising the risk of bleeding. Patients on warfarin require close monitoring.
  • Cimetidine: This medication can increase mirtazapine levels in the body, which may intensify side effects.

Medical Conditions Requiring Vigilance

Heart and Cardiovascular Conditions

Mirtazapine can cause low blood pressure, especially when standing up quickly (orthostatic hypotension), which can be dangerous for those with a history of heart attack, stroke, or heart disease. It can also, rarely, cause a prolonged QT interval, a heart rhythm abnormality.

Liver and Kidney Impairment

Patients with moderate to severe liver or kidney problems may experience an increased concentration of mirtazapine in their body due to slower clearance. This can increase side effects, and a lower dose is often required.

Bipolar Disorder and Seizure History

Mirtazapine should not be taken by individuals with undiagnosed bipolar disorder, as antidepressants can trigger a manic or hypomanic episode. Those with a history of seizures should also use mirtazapine with caution, as it can, in rare cases, increase seizure risk.

Angle-Closure Glaucoma

This medication can trigger an attack in patients with angle-closure glaucoma. An eye exam before starting treatment is often recommended, and any vision changes or eye pain should be reported immediately.

Key Actions and Behaviors to Never Do

Never Stop Abruptly

Stopping mirtazapine suddenly can cause withdrawal symptoms, a condition known as antidepressant discontinuation syndrome. Symptoms can include dizziness, nausea, vivid dreams, headaches, and a pins-and-needles sensation. Your doctor must gradually reduce your dose over time to ensure a safe and smooth discontinuation.

Avoid Driving and Operating Heavy Machinery

Due to its sedative effects, especially when first starting treatment or after a dose change, mirtazapine can impair cognitive and motor skills. You must know how the medication affects you before engaging in activities that require full mental alertness.

Do Not Alter Doses Without Medical Advice

Taking more mirtazapine than prescribed increases the risk of side effects, toxicity, and overdose. Taking less or missing doses can lead to a return of depressive symptoms. Always follow your doctor's exact instructions.

Handle Orally Disintegrating Tablets Correctly

Do not split or crush orally disintegrating mirtazapine tablets. They must remain in their original blister pack until you are ready to take them, and they cannot be stored once removed.

Considerations for Special Populations

Elderly Patients

Elderly patients are at a higher risk of confusion, over-sedation, and hyponatremia (low sodium levels) with mirtazapine. They are often prescribed lower starting doses and require close monitoring to minimize fall risk.

Children and Young Adults

Antidepressants, including mirtazapine, carry a boxed warning about an increased risk of suicidal thoughts and behaviors in young adults up to age 24, particularly during initial treatment or dose adjustments. Close monitoring by family and caregivers is essential.

Pregnant and Breastfeeding Individuals

While research is ongoing, potential risks to the fetus or infant exist with mirtazapine use. The decision to use it during pregnancy or breastfeeding should be made in careful consultation with a healthcare provider, weighing the potential benefits against the risks.

Mirtazapine vs. Selective Serotonin Reuptake Inhibitors (SSRIs) Adverse Effects

Side Effect Mirtazapine SSRIs
Sedation/Drowsiness More likely (prominent, especially at lower doses) Less likely (more activating for some)
Increased Appetite/Weight Gain More likely Less likely (but can occur)
Nausea/Vomiting Less likely More likely, especially when starting
Sexual Dysfunction Less likely More likely
Insomnia/Restlessness Less likely (due to sedative nature) Can be a notable side effect
Headaches Possible, but side effects often improve over weeks Common, especially at treatment onset

Conclusion

For effective and safe treatment with mirtazapine, it is critical to adhere strictly to your healthcare provider's instructions. Major risks include severe drug interactions, especially with MAOIs and alcohol, and potential effects on vulnerable populations and specific health conditions. Never stop taking mirtazapine abruptly or change your dose without medical guidance. Close monitoring for side effects, particularly increased suicidal thoughts in younger patients, is necessary. By following these clear precautions, patients can maximize the therapeutic benefits of mirtazapine while minimizing potential harm. For comprehensive information and the latest guidance, always consult the manufacturer's medication guide provided by your pharmacist or visit the FDA website.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any decisions about your treatment plan or medications.

Frequently Asked Questions

No, it is highly discouraged to drink alcohol while taking mirtazapine. Both substances depress the central nervous system, and combining them can cause severe drowsiness, impaired coordination, and increase the risk of serious side effects.

Stopping mirtazapine abruptly can lead to withdrawal symptoms, which include dizziness, nausea, anxiety, agitation, and sensory disturbances. Your doctor must create a plan for gradually reducing your dose to avoid these effects.

Yes, you should never take mirtazapine with or within 14 days of taking a Monoamine Oxidase Inhibitor (MAOI), such as phenelzine, tranylcypromine, or linezolid. This combination can cause a dangerous condition called serotonin syndrome.

Taking mirtazapine with other serotonergic medications, including many other antidepressants (SSRIs, SNRIs), can increase the risk of serotonin syndrome. This is a serious condition caused by too much serotonin in the brain.

Mirtazapine can cause drowsiness and dizziness, especially when you first start taking it. Do not drive or operate heavy machinery until you know how the medication affects your ability to concentrate and react.

Elderly patients are more susceptible to the sedative effects of mirtazapine, which can lead to confusion and increased risk of falls. There is also a higher risk of developing low sodium levels (hyponatremia). Lower starting doses are often used.

Mirtazapine carries a boxed warning about an increased risk of suicidal thoughts and behavior, especially in children, teenagers, and young adults under 25. Patients and caregivers should monitor for new or worsening symptoms, particularly when starting or changing the dose.

References

  1. 1
  2. 2
  3. 3
  4. 4

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.